Skip to main content

Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME® Model

  • 2020-07-11
  • Microorganisms 8(7)
    • M. Marzorati
    • P. Abbeele
    • Sarah S Bubeck
    • Thomas Bayne
    • K. Krishnan
    • Aicacia Young
    • D. Mehta
    • A. DeSouza

Abstract

Benefits associated with probiotic use have been reported; however, the mechanisms behind these benefits are poorly understood. The effects of a probiotic formulation (MegaDuo™) containing Bacillus coagulans SC208 and Bacillus subtilis HU58 on intestinal permeability and immune markers was assessed using a combination of the in vitro gut model, the mucosal simulator of the human intestinal microbial ecosystem (M-SHIME®), and an in vitro inflammatory bowel disease-like Caco-2/THP1 co-culture model in both healthy and antibiotic-induced dysbiosis conditions. Established M-SHIME® proximal colon vessels were treated with/without clindamycin (1 week) and then with/without daily MegaDuo™ treatment (2 weeks). The mucosal and luminal microbial communities were sampled weekly. Suspensions were removed from the proximal colon vessels after 1 and 2 weeks of MegaDuo™ treatment and added to the co-culture system. Transepithelial resistance (membrane barrier function), cytokine/chemokine release, and NFκB activity were then measured. Under conditions of antibiotic-induced dysbiosis, suspensions from MegaDuo™ treated vessels showed reduced gut membrane barrier damage and decreased levels of TNFα and IL-6 compared with suspensions from untreated vessels; no appreciable differences were observed under healthy conditions. MegaDuo™ treatment had no effect on NFκB activity of THP1-Blue™ cells. The potential benefits of MegaDuo™ treatment appeared most evident after 2 weeks of treatment.

Keywords: M-SHIME; dysbiosis; gut barrier; gut inflammation; gut microbiome; immunomodulation; probiotics.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus coagulans SC208Reduced Gut Membrane Barrier DamageBeneficial
Moderate
Bacillus subtilis HU58Reduced Gut Barrier DefectBeneficial
Moderate
Bacillus subtilis HU58Reduced Interleukin-6 LevelsBeneficial
Moderate
Bacillus subtilis HU58Reduced TNF-α LevelsBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.